Dasatinib Carboxylic Acid Ethyl Ester structure
|
Common Name | Dasatinib Carboxylic Acid Ethyl Ester | ||
|---|---|---|---|---|
| CAS Number | 910297-62-0 | Molecular Weight | 530.04200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H28ClN7O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | ethyl 2-[4-[6-[[5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazin-1-yl]acetate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C24H28ClN7O3S |
|---|---|
| Molecular Weight | 530.04200 |
| Exact Mass | 529.16600 |
| PSA | 144.31000 |
| LogP | 4.34420 |
| InChIKey | LTKNTZZGCSNLFZ-UHFFFAOYSA-N |
| SMILES | CCOC(=O)CN1CCN(c2cc(Nc3ncc(C(=O)Nc4c(C)cccc4Cl)s3)nc(C)n2)CC1 |
|
~89%
Dasatinib Carbo... CAS#:910297-62-0 |
| Literature: CURIS, INC. Patent: WO2008/33746 A2, 2008 ; Location in patent: Page/Page column 58 ; WO 2008/033746 A2 |
|
~89%
Dasatinib Carbo... CAS#:910297-62-0 |
| Literature: Bristol-Myers Squibb Company Patent: US2007/219370 A1, 2007 ; Location in patent: Page/Page column 29 ; |
| 4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid Ethyl Ester |
| ethyl 2-(4-(6-(5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-ylamino)-2-methylpyrimidin-4-yl)piperazin-1-yl)acetate |
| Dasatinib Carboxylic Acid Ethyl Ester |
| Dasatinib Impurity 2 |